1 / 21

Eosinophilic Esophagitis Drug Market – Overview on Key Innovations 2028

The market for eosinophilic esophagitis drug is driven by the growing prevalence of type II inflammatory disorders including EoE, advances in the treatment procedures, and intense competition among players for the first FDA approved drug to have a first-mover advantage. Huge unmet in EoE is also favoring the growth of the eosinophilic esophagitis drug industry.

priyanka1988
Download Presentation

Eosinophilic Esophagitis Drug Market – Overview on Key Innovations 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Eosinophilic Esophagitis Drug Market Market Size Worth US$ 189.7 Million by 2028 | CAGR: 6.5%

  2. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 “According to Polaris Market Research report, Eosinophilic Esophagitis Drug market is witnessing a major transformation and is projected to reach US$ 189.7 Million by 2028 registering a CAGR of 6.5% during the forecast period 2021 to 2028.” The global Eosinophilic Esophagitis Drug market growth is driven by some of the key factors such as growing awareness among consumers, increasing investments by private-public organizations, and favorable government policies. Additionally, many prominent players present in the market are concentrating on the adoption of new technology and product launches to obtain a competitive edge, which in turn contributes to the Eosinophilic Esophagitis Drug market growth. The regulatory agencies are also playing a key role as the major driving force for the market, by safeguarding the quality of product/service offerings as well as accelerating new approvals. Eosinophilic Esophagitis Drug Market Report Scope: The study provides a comprehensive view of the Eosinophilic Esophagitis Drug market by segmenting it based on Product, Diagnosis, Treatment and region. All the segments of the market have been thoroughly analyzed based on present and future trends. The research report has identified the key segments contributing most to the Eosinophilic Esophagitis Drug market growth in terms of revenue along with other vital factors impacting the market dynamics. Further, the market analysis covered in the report also answers the imperative question for new entrants and existing players operating in the market. Browse Detailed Research Report On Eosinophilic Esophagitis Drug Market Analysis: https://www.polarismarketresearch.com/industry-analysis/eosinophilic-esophagitis-drug-market - 2 -

  3. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 By Product By Diagnosis By Treatment By Region •Off-Label Drugs •Budesonide Oral Suspension •Fluticasone ODT •Mepolizumab •Reslizumab •Benralizumab •Dupilunab •Omalizumab •QAX576 •AKOO2 •Losartan •Upper Endoscopy •Esophagus Biopsy •Blood Tests •Others •Dietary Therapy •Medication •Dilation •Others •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) Impact Analysis of COVID-19 on Eosinophilic Esophagitis Drug Market The global Eosinophilic Esophagitis Drug market is anticipated to continue its growth amid the covid-19 pandemic. After giving insightful information on market behavior pre and post COVID-19 pandemic, the report also sheds light on the key strategic moves to overcome the adverse impact of COVID-19 on business and turn the positive impact into a lucrative opportunity. Regional Outlook The regional market of North America is witnessing a significant rise in the growth rate and is expected to account for the largest market share over the forecast period. The market is flourishing as a result of its increasing application scope and ample availability of vital resources. During the forecast period, the Asia Pacific region is estimated to garner the highest CAGR for the Eosinophilic Esophagitis Drug market, owing to the presence of several leading local and international players operating in the regional market. Gain access to our latest research report that includes a detailed analysis of the COVID-19 pandemic influencing the Eosinophilic Esophagitis Drug market in different regions and how market players devising effective strategies to mitigate the effect of the pandemic: https://www.polarismarketresearch.com/industry-analysis/eosinophilic-esophagitis-drug-market/speak- to-analyst - 3 -

  4. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 Competitive Landscape Leading companies holding significant market shares in the Eosinophilic Esophagitis Drug market are analyzed considering their market shares, growth rates, market revenue, business strategies, and latest developments. Recent events for these major companies such as acquisitions, research initiatives, technological advancements, new solution/product launches, and geographical expansions considered in finalizing their position in the market. According to Polaris Market Research, the leading players with a noteworthy share in the Eosinophilic Esophagitis Drug market include Regeneron Pharmaceuticals, Adare Pharmaceuticals, Inc., Bristol-Myers Squibb, Takeda (Shire), DBV Technologies, Dr. Falk Pharma GmbH, Allakos, Inc., Arena Pharmaceuticals, and Ception Therapeutics. Request for sample: https://www.polarismarketresearch.com/industry-analysis/eosinophilic-esophagitis- drug-market/request-for-sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Eosinophilic Esophagitis Drug Market Insights 4.1.Eosinophilic Esophagitis Drug - Industry snapshot 4.2.Eosinophilic Esophagitis Drug Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. Strong Drug Pipeline - 4 -

  5. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 4.2.1.2. 4.2.2.Restraints and Challenges 4.2.2.1. Adverse Reactions 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4.PESTLE Analysis 4.5.Eosinophilic Esophagitis Drug Market Industry trends 5.Eosinophilic Esophagitis Drug Market Assessment by Product 5.1.Key Findings 5.2.Introduction 5.2.1.Global Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 5.3.Off-Label Drugs 5.3.1.Global Eosinophilic Esophagitis Drug Market, by Off-Label Drugs, by Region, 2016 - 2028 (USD Million) 5.4.Budesonide Oral Suspension 5.4.1.Global Eosinophilic Esophagitis Drug Market, by Budesonide Oral Suspension, by Region, 2016 - 2028 (USD Million) 5.5.Fluticasone ODT 5.5.1.Global Eosinophilic Esophagitis Drug Market, by Fluticasone ODT, by Region, 2016 - 2028 (USD Million) 5.6.Mepolizumab 5.6.1.Global Eosinophilic Esophagitis Drug Market, by Mepolizumab, by Region, 2016 - 2028 (USD Million) 5.7.Reslizumab 5.7.1.Global Eosinophilic Esophagitis Drug Market, by Reslizumab, by Region, 2016 - 2028 (USD Million) 5.8.Benralizumab 5.8.1.Global Eosinophilic Esophagitis Drug Market, by Benralizumab, by Region, 2016 - 2028 (USD Million) 5.9.Dupilunab 5.9.1.Global Eosinophilic Esophagitis Drug Market, by Dupilunab, by Region, 2016 - 2028 (USD Million) 5.10. Omalizumab Aging Population - 5 -

  6. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 5.10.1.Global Eosinophilic Esophagitis Drug Market, by Omalizumab, by Region, 2016 - 2028 (USD Million) 5.11. QAX576 5.11.1.Global Eosinophilic Esophagitis Drug Market, by QAX576, by Region, 2016 - 2028 (USD Million) 5.12. AKOO2 5.12.1.Global Eosinophilic Esophagitis Drug Market, by AKOO2, by Region, 2016 - 2028 (USD Million) 5.13. Losartan 5.13.1.Global Eosinophilic Esophagitis Drug Market, by Losartan, by Region, 2016 - 2028 (USD Million) 6.Global Eosinophilic Esophagitis Drug Market, by Diagnosis 6.1.Key Findings 6.2.Introduction 6.2.1.Global Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 6.3.Upper Endoscopy 6.3.1.Global Eosinophilic Esophagitis Drug Market, by Upper Endoscopy, By Region, 2016 - 2028 (USD Million) 6.4.Esophagus Biopsy 6.4.1.Global Eosinophilic Esophagitis Drug Market, by Esophagus Biopsy, by Region, 2016 - 2028 (USD Million) 6.5.Blood Tests 6.5.1.Global Eosinophilic Esophagitis Drug Market, by Blood Tests, by Region, 2016 - 2028 (USD Million) 6.6.Others 6.6.1.Global Eosinophilic Esophagitis Drug Market, by Others by Region, 2016 - 2028 (USD Million) 7.Eosinophilic Esophagitis Drug Market Assessment by Treatment 7.1.Key Findings 7.2.Introduction 7.2.1.Global Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 7.3.Dietary Therapy 7.3.1.Global Eosinophilic Esophagitis Drug Market, by Dietary Therapy, by Region, 2016 - 2028 (USD Million) 7.4.Medication - 6 -

  7. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 7.4.1.Global Eosinophilic Esophagitis Drug Market, by Medication, by Region, 2016 - 2028 (USD Million) 7.5.Dilation 7.5.1.Global Eosinophilic Esophagitis Drug Market, by Dilation, by Region, 2016 - 2028 (USD Million) 7.6.Others 7.6.1.Global Eosinophilic Esophagitis Drug Market, by Others, by Region, 2016 - 2028 (USD Million) 8.Eosinophilic Esophagitis Drug Market Assessment by Geography 8.1.Key findings 8.2.Introduction 8.2.1.Eosinophilic Esophagitis Drug Market Assessment, By Geography, 2016 - 2028 (USD Million) 8.3.Eosinophilic Esophagitis Drug Market - North America 8.3.1.North America: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.3.2.North America: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.3.3.North America: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.3.4.Eosinophilic Esophagitis Drug Market - U.S. 8.3.4.1. U.S.: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.3.4.2. U.S.: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.3.4.3. U.S.: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.3.5.Eosinophilic Esophagitis Drug Market - Canada 8.3.5.1. Canada: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.3.5.2. Canada: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.3.5.3. Canada: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.4.Eosinophilic Esophagitis Drug Market - Europe 8.4.1.Europe: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.4.2.Europe.: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.4.3.Europe: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) - 7 -

  8. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 8.4.4.Eosinophilic Esophagitis Drug Market - UK 8.4.4.1. UK: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.4.4.2. UK: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.4.4.3. UK: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.4.5.Eosinophilic Esophagitis Drug Market - France 8.4.5.1. France: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.4.5.2. France: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.4.5.3. France: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.4.6.Eosinophilic Esophagitis Drug Market - Germany 8.4.6.1. Germany: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.4.6.2. Germany: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.4.6.3. Germany: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.4.7.Eosinophilic Esophagitis Drug Market - Italy 8.4.7.1. Italy: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.4.7.2. Italy: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.4.7.3. Italy: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.4.8.Eosinophilic Esophagitis Drug Market - Spain 8.4.8.1. Spain: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.4.8.2. Spain: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.4.8.3. Spain: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.4.9.Eosinophilic Esophagitis Drug Market - Netherlands 8.4.9.1. Netherlands: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.4.9.2. Netherlands: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.4.9.3. Netherlands: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.4.10.Eosinophilic Esophagitis Drug Market - Austria - 8 -

  9. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 8.4.10.1.Austria: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.4.10.2.Austria: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.4.10.3.Austria: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.5.Eosinophilic Esophagitis Drug Market - Asia-Pacific 8.5.1.Asia Pacific: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.5.2.Asia Pacific: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.5.3.Asia Pacific: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.5.4.Eosinophilic Esophagitis Drug Market - China 8.5.4.1. China: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.5.4.2. China: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.5.4.3. China: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.5.5.Eosinophilic Esophagitis Drug Market - India 8.5.5.1. India: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.5.5.2. India: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.5.5.3. India: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.5.6.Eosinophilic Esophagitis Drug Market - Malaysia 8.5.6.1. Malaysia: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.5.6.2. Malaysia: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.5.6.3. Malaysia: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.5.7.Eosinophilic Esophagitis Drug Market - Japan 8.5.7.1. Japan: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.5.7.2. Japan: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.5.7.3. Japan: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.5.8.Eosinophilic Esophagitis Drug Market - Indonesia 8.5.8.1. Indonesia: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) - 9 -

  10. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 8.5.8.2. Indonesia: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.5.8.3. Indonesia: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.5.9.Eosinophilic Esophagitis Drug Market - South Korea 8.5.9.1. South Korea: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.5.9.2. South Korea: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.5.9.3. South Korea: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.6.Eosinophilic Esophagitis Drug Market - Middle East & Africa 8.6.1.Middle East & Africa: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.6.2.Middle East & Africa: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.6.3.Middle East & Africa: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.6.4.Eosinophilic Esophagitis Drug Market - Saudi Arabia 8.6.4.1. Saudi Arabia: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.6.4.2. Saudi Arabia: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.6.4.3. Saudi Arabia: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.6.5.Eosinophilic Esophagitis Drug Market - UAE 8.6.5.1. UAE: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.6.5.2. UAE: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.6.5.3. UAE: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.6.6.Eosinophilic Esophagitis Drug Market - Israel 8.6.6.1. Israel: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.6.6.2. Israel: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.6.6.3. Israel: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.6.7.Eosinophilic Esophagitis Drug Market - South Africa 8.6.7.1. South Africa: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.6.7.2. South Africa: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) - 10 -

  11. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 8.6.7.3. South Africa: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.7.Eosinophilic Esophagitis Drug Market - Latin America 8.7.1.Latin America: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.7.2.Latin America: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.7.3.Latin America: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.7.4.Eosinophilic Esophagitis Drug Market - Mexico 8.7.4.1. Mexico: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.7.4.2. Mexico: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.7.4.3. Mexico: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.7.5.Eosinophilic Esophagitis Drug Market - Brazil 8.7.5.1. Brazil: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.7.5.2. Brazil: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.7.5.3. Brazil: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 8.7.6.Eosinophilic Esophagitis Drug Market - Argentina 8.7.6.1. Argentina: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 8.7.6.2. Argentina: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 8.7.6.3. Argentina: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 9.Competitive Landscape 9.1.Expansion and Acquisition Analysis 9.1.1.Expansion 9.1.2.Acquisition 9.2.Partnerships/Collaborations/Agreements/Exhibitions 10.Company Profiles 10.1. Regeneron Pharmaceuticals 10.1.1.Company Overview 10.1.2.Financial Performance 10.1.3.Product/Services Benchmarking 10.1.4.Recent Development - 11 -

  12. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 10.2. Bristol-Myers Squibb, Takeda (Shire) 10.2.1.Company Overview 10.2.2.Financial Performance 10.2.3.Product/Services Benchmarking 10.2.4.Recent Development 10.3. DBV Technologies 10.3.1.Company Overview 10.3.2.Financial Performance 10.3.3.Product/Services Benchmarking 10.3.4.Recent Development 10.4. AstraZeneca 10.4.1.Company Overview 10.4.2.Financial Performance 10.4.3.Product/Services Benchmarking 10.4.4.Recent Development 10.5. Dr. Falk Pharma GmbH 10.5.1.Company Overview 10.5.2.Financial Performance 10.5.3.Product/Services Benchmarking 10.5.4.Recent Development 10.6. Allakos, Inc. 10.6.1.Company Overview 10.6.2.Financial Performance 10.6.3.Product/Services Benchmarking 10.6.4.Recent Development 10.7. Arena Pharmaceuticals 10.7.1.Company Overview 10.7.2.Financial Performance 10.7.3.Product/Services Benchmarking 10.7.4.Recent Development 10.8. Ception Therapeutics 10.8.1.Company Overview 10.8.2.Financial Performance 10.8.3.Product/Services Benchmarking 10.8.4.Recent Development 11.Introduction 11.1. Report Description 11.1.1.Objectives of the Study 11.1.2.Market Scope 11.1.3.Assumptions 11.2. Stakeholders - 12 -

  13. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 12.Executive Summary 12.1. 13.Research Methodology 13.1. 13.1.1.Data Mining 13.2. 13.2.1.Primary Sources 13.2.2.Secondary Sources 14.Eosinophilic Esophagitis Drug Market Insights 14.1. Eosinophilic Esophagitis Drug - Industry snapshot 14.2. Eosinophilic Esophagitis Drug Market Dynamics 14.2.1.Drivers and Opportunities 14.2.1.1.Strong Drug Pipeline 14.2.1.2.Aging Population 14.2.2.Restraints and Challenges 14.2.2.1.Adverse Reactions 14.3. Porter’s Five Forces Analysis 14.3.1.Bargaining Power of Suppliers (Moderate) 14.3.2.Threats of New Entrants: (Low) 14.3.3.Bargaining Power of Buyers (Moderate) 14.3.4.Threat of Substitute (Moderate) 14.3.5.Rivalry among existing firms (High) 14.4. PESTLE Analysis 14.5. Eosinophilic Esophagitis Drug Market Industry trends 15.Eosinophilic Esophagitis Drug Market Assessment by Product 15.1. Key Findings 15.2. Introduction 15.2.1.Global Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 15.3. Off-Label Drugs 15.3.1.Global Eosinophilic Esophagitis Drug Market, by Off-Label Drugs, by Region, 2016 - 2028 (USD Million) 15.4. Budesonide Oral Suspension 15.4.1.Global Eosinophilic Esophagitis Drug Market, by Budesonide Oral Suspension, by Region, 2016 - 2028 (USD Million) 15.5. Fluticasone ODT Market Highlights Overview Data Sources - 13 -

  14. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 15.5.1.Global Eosinophilic Esophagitis Drug Market, by Fluticasone ODT, by Region, 2016 - 2028 (USD Million) 15.6. Mepolizumab 15.6.1.Global Eosinophilic Esophagitis Drug Market, by Mepolizumab, by Region, 2016 - 2028 (USD Million) 15.7. Reslizumab 15.7.1.Global Eosinophilic Esophagitis Drug Market, by Reslizumab, by Region, 2016 - 2028 (USD Million) 15.8. Benralizumab 15.8.1.Global Eosinophilic Esophagitis Drug Market, by Benralizumab, by Region, 2016 - 2028 (USD Million) 15.9. Dupilunab 15.9.1.Global Eosinophilic Esophagitis Drug Market, by Dupilunab, by Region, 2016 - 2028 (USD Million) 15.10. Omalizumab 15.10.1. Global Eosinophilic Esophagitis Drug Market, by Omalizumab, by Region, 2016 - 2028 (USD Million) 15.11. QAX576 15.11.1. Global Eosinophilic Esophagitis Drug Market, by QAX576, by Region, 2016 - 2028 (USD Million) 15.12. AKOO2 15.12.1. Global Eosinophilic Esophagitis Drug Market, by AKOO2, by Region, 2016 - 2028 (USD Million) 15.13. Losartan 15.13.1. Global Eosinophilic Esophagitis Drug Market, by Losartan, by Region, 2016 - 2028 (USD Million) 16.Global Eosinophilic Esophagitis Drug Market, by Diagnosis 16.1. Key Findings 16.2. Introduction 16.2.1.Global Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 16.3. Upper Endoscopy 16.3.1.Global Eosinophilic Esophagitis Drug Market, by Upper Endoscopy, By Region, 2016 - 2028 (USD Million) 16.4. Esophagus Biopsy 16.4.1.Global Eosinophilic Esophagitis Drug Market, by Esophagus Biopsy, by Region, 2016 - 2028 (USD Million) - 14 -

  15. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 16.5. Blood Tests 16.5.1.Global Eosinophilic Esophagitis Drug Market, by Blood Tests, by Region, 2016 - 2028 (USD Million) 16.6. Others 16.6.1.Global Eosinophilic Esophagitis Drug Market, by Others by Region, 2016 - 2028 (USD Million) 17.Eosinophilic Esophagitis Drug Market Assessment by Treatment 17.1. Key Findings 17.2. Introduction 17.2.1.Global Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 17.3. Dietary Therapy 17.3.1.Global Eosinophilic Esophagitis Drug Market, by Dietary Therapy, by Region, 2016 - 2028 (USD Million) 17.4. Medication 17.4.1.Global Eosinophilic Esophagitis Drug Market, by Medication, by Region, 2016 - 2028 (USD Million) 17.5. Dilation 17.5.1.Global Eosinophilic Esophagitis Drug Market, by Dilation, by Region, 2016 - 2028 (USD Million) 17.6. Others 17.6.1.Global Eosinophilic Esophagitis Drug Market, by Others, by Region, 2016 - 2028 (USD Million) 18.Eosinophilic Esophagitis Drug Market Assessment by Geography 18.1. Key findings 18.2. Introduction 18.2.1.Eosinophilic Esophagitis Drug Market Assessment, By Geography, 2016 - 2028 (USD Million) 18.3. Eosinophilic Esophagitis Drug Market - North America 18.3.1.North America: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.3.2.North America: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.3.3.North America: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.3.4.Eosinophilic Esophagitis Drug Market - U.S. 18.3.4.1.U.S.: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) - 15 -

  16. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 18.3.4.2.U.S.: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.3.4.3.U.S.: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.3.5.Eosinophilic Esophagitis Drug Market - Canada 18.3.5.1.Canada: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.3.5.2.Canada: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.3.5.3.Canada: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.4. Eosinophilic Esophagitis Drug Market - Europe 18.4.1.Europe: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.4.2.Europe.: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.4.3.Europe: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.4.4.Eosinophilic Esophagitis Drug Market - UK 18.4.4.1.UK: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.4.4.2.UK: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.4.4.3.UK: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.4.5.Eosinophilic Esophagitis Drug Market - France 18.4.5.1.France: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.4.5.2.France: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.4.5.3.France: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.4.6.Eosinophilic Esophagitis Drug Market - Germany 18.4.6.1.Germany: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.4.6.2.Germany: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.4.6.3.Germany: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.4.7.Eosinophilic Esophagitis Drug Market - Italy 18.4.7.1.Italy: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.4.7.2.Italy: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) - 16 -

  17. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 18.4.7.3.Italy: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.4.8.Eosinophilic Esophagitis Drug Market - Spain 18.4.8.1.Spain: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.4.8.2.Spain: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.4.8.3.Spain: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.4.9.Eosinophilic Esophagitis Drug Market - Netherlands 18.4.9.1.Netherlands: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.4.9.2.Netherlands: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.4.9.3.Netherlands: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.4.10. Eosinophilic Esophagitis Drug Market - Austria 18.4.10.1.Austria: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.4.10.2.Austria: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.4.10.3.Austria: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.5. Eosinophilic Esophagitis Drug Market - Asia-Pacific 18.5.1.Asia Pacific: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.5.2.Asia Pacific: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.5.3.Asia Pacific: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.5.4.Eosinophilic Esophagitis Drug Market - China 18.5.4.1.China: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.5.4.2.China: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.5.4.3.China: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.5.5.Eosinophilic Esophagitis Drug Market - India 18.5.5.1.India: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.5.5.2.India: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.5.5.3.India: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) - 17 -

  18. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 18.5.6.Eosinophilic Esophagitis Drug Market - Malaysia 18.5.6.1.Malaysia: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.5.6.2.Malaysia: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.5.6.3.Malaysia: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.5.7.Eosinophilic Esophagitis Drug Market - Japan 18.5.7.1.Japan: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.5.7.2.Japan: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.5.7.3.Japan: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.5.8.Eosinophilic Esophagitis Drug Market - Indonesia 18.5.8.1.Indonesia: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.5.8.2.Indonesia: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.5.8.3.Indonesia: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.5.9.Eosinophilic Esophagitis Drug Market - South Korea 18.5.9.1.South Korea: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.5.9.2.South Korea: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.5.9.3.South Korea: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.6. Eosinophilic Esophagitis Drug Market - Middle East & Africa 18.6.1.Middle East & Africa: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.6.2.Middle East & Africa: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.6.3.Middle East & Africa: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.6.4.Eosinophilic Esophagitis Drug Market - Saudi Arabia 18.6.4.1.Saudi Arabia: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.6.4.2.Saudi Arabia: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.6.4.3.Saudi Arabia: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.6.5.Eosinophilic Esophagitis Drug Market - UAE - 18 -

  19. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 18.6.5.1.UAE: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.6.5.2.UAE: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.6.5.3.UAE: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.6.6.Eosinophilic Esophagitis Drug Market - Israel 18.6.6.1.Israel: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.6.6.2.Israel: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.6.6.3.Israel: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.6.7.Eosinophilic Esophagitis Drug Market - South Africa 18.6.7.1.South Africa: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.6.7.2.South Africa: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.6.7.3.South Africa: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.7. Eosinophilic Esophagitis Drug Market - Latin America 18.7.1.Latin America: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.7.2.Latin America: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.7.3.Latin America: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.7.4.Eosinophilic Esophagitis Drug Market - Mexico 18.7.4.1.Mexico: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.7.4.2.Mexico: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.7.4.3.Mexico: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.7.5.Eosinophilic Esophagitis Drug Market - Brazil 18.7.5.1.Brazil: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) 18.7.5.2.Brazil: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.7.5.3.Brazil: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 18.7.6.Eosinophilic Esophagitis Drug Market - Argentina 18.7.6.1.Argentina: Eosinophilic Esophagitis Drug Market, By Product, 2016 - 2028 (USD Million) - 19 -

  20. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 18.7.6.2.Argentina: Eosinophilic Esophagitis Drug Market, By Diagnosis, 2016 - 2028 (USD Million) 18.7.6.3.Argentina: Eosinophilic Esophagitis Drug Market, By Treatment, 2016 - 2028 (USD Million) 19.Competitive Landscape 19.1. Expansion and Acquisition Analysis 19.1.1.Expansion 19.1.2.Acquisition 19.2. Partnerships/Collaborations/Agreements/Exhibitions 20.Company Profiles 20.1. Regeneron Pharmaceuticals 20.1.1.Company Overview 20.1.2.Financial Performance 20.1.3.Product/Services Benchmarking 20.1.4.Recent Development 20.2. Bristol-Myers Squibb, Takeda (Shire) 20.2.1.Company Overview 20.2.2.Financial Performance 20.2.3.Product/Services Benchmarking 20.2.4.Recent Development 20.3. DBV Technologies 20.3.1.Company Overview 20.3.2.Financial Performance 20.3.3.Product/Services Benchmarking 20.3.4.Recent Development 20.4. AstraZeneca 20.4.1.Company Overview 20.4.2.Financial Performance 20.4.3.Product/Services Benchmarking 20.4.4.Recent Development 20.5. Dr. Falk Pharma GmbH 20.5.1.Company Overview 20.5.2.Financial Performance 20.5.3.Product/Services Benchmarking 20.5.4.Recent Development 20.6. Allakos, Inc. 20.6.1.Company Overview 20.6.2.Financial Performance 20.6.3.Product/Services Benchmarking 20.6.4.Recent Development - 20 -

  21. Eosinophilic Esophagitis Drug Market Size Worth US$ 189.7 Million by 2028 20.7. Arena Pharmaceuticals 20.7.1.Company Overview 20.7.2.Financial Performance 20.7.3.Product/Services Benchmarking 20.7.4.Recent Development 20.8. Ception Therapeutics 20.8.1.Company Overview 20.8.2.Financial Performance 20.8.3.Product/Services Benchmarking 20.8.4.Recent Development Access Press Release on Eosinophilic Esophagitis Drug Market: https://www.polarismarketresearch.com/press-releases/eosinophilic-esophagitis-drug-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 21 -

More Related